Q1 FY27 results: Rs 81 lakh profit, board approves Lyka BDR divestment

Revenue DeclineResults RestatedExceptional ItemResults View source PDF Explain this filing

LYKALABS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.0%Reaction day

₹66.75

prior close

₹67.10

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%+2.0% vs market

Pharmaceuticals peers, median of 165sector-0.1%+2.1% vs sector

On the reaction day the stock moved 2.0 pts more than Nifty Microcap 250 and 2.1 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.0-0.1+2.0-0.1+2.1

Next day

+1.5-0.2+1.7+0.0+1.4

+0.0+0.1-0.1-0.1+0.1

+1.9+0.3+1.6+0.2+1.7

-0.1+0.4-0.5-0.6+0.6

+1.9+0.5+1.4-1.2+3.1

+6.0+0.3+5.7-2.0+8.0

15d

+12.9+1.9+11.0+0.1+12.8

+26.1+2.2+24.0+1.4+24.8

+9.1-1.2+10.3-2.0+11.2

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q1 FY27 standalone PAT of Rs 81.07 lakh versus restated loss of Rs 2,977 lakh YoY. Consolidated PAT Rs 99.62 lakh. Standalone revenue from ops at Rs 2,803 lakh (vs Rs 2,918 lakh YoY); consolidated revenue at Rs 2,803 lakh (vs Rs 3,303 lakh). Board approved 100 percent divestment of subsidiary Lyka BDR International (8 percent of consolidated income, net worth negative Rs 449 lakh). Unqualified auditor opinion. Results restated due to NCLT-approved merger with Lyka Export.

Likely market impact

Turnaround to profit from restated loss is positive, but revenue continues declining. Subsidiary divestment simplifies group structure.